Literature DB >> 9167986

Cognitive and psychomotor performance tests and experiment design in multiple chemical sensitivity.

A Wetherell1.   

Abstract

People suffering from multiple chemical sensitivity (MCS) complain of a variety of symptoms that could impair cognitive and psychomotor function either directly or indirectly. This paper discusses the use of cognitive and psychomotor performance tests together with some experiment designs that could be considered for use to assess fitness of MCS sufferers for work or the efficacy of diagnostic, preventative, or therapeutic measures. The tests could also contribute to the body of objective information on MCS and help sway the opinion of those who are dubious of its authenticity. The credentials of cognitive and psychomotor performance tests are derived from their successful use in studying the effects of drugs, and the types of tests are illustrated by describing those used by the United Kingdom Defence Evaluation and Research Agency Chemical and Biological Defence Human Studies Group, which has been involved in the assessment of drugs and chemicals on work performance for many years. The tests include mathematical, verbal and spatial processing, tracking, reaction time, attention and vigilance, and memory tests. The discussion of experiment designs includes both repeated measures and parallel groups designs together with their advantages and disadvantages and some suggested modifications to accommodate the particular problems posed by MCS.

Entities:  

Mesh:

Year:  1997        PMID: 9167986      PMCID: PMC1469819          DOI: 10.1289/ehp.97105s2495

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  18 in total

1.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Work schedules and performance during confinement.

Authors:  W D Chiles; E A Alluisi; O S Adams
Journal:  Hum Factors       Date:  1968-04       Impact factor: 2.888

3.  Behavioural evaluation of workers exposed to mixtures of organic solvents.

Authors:  N A Maizlish; G D Langolf; L W Whitehead; L J Fine; J W Albers; J Goldberg; P Smith
Journal:  Br J Ind Med       Date:  1985-09

4.  Some effects of atropine on short-term memory.

Authors:  A Wetherell
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

Review 5.  Smoking, nicotine and human performance.

Authors:  K Wesnes; D M Warburton
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

6.  A Trimix saturation dive to 660 m. Studies of cognitive performance, mood and sleep quality.

Authors:  R H Logie; A D Baddeley
Journal:  Ergonomics       Date:  1983-04       Impact factor: 2.778

Review 7.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Cognitive performance, sleep quality and mood during deep oxyhelium diving.

Authors:  V J Lewis; A D Baddeley
Journal:  Ergonomics       Date:  1981-10       Impact factor: 2.778

9.  The use of Sternberg's memory-scanning paradigm in assessing effects of chemical exposure.

Authors:  P J Smith; G D Langolf
Journal:  Hum Factors       Date:  1981-12       Impact factor: 2.888

10.  Tapping regularity as a measure of perceptual motor load.

Authors:  J A Michon
Journal:  Ergonomics       Date:  1966-09       Impact factor: 2.778

View more
  3 in total

1.  Experimental approaches to chemical sensitivity: introduction and overview.

Authors:  H Kipen; N Fiedler
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

2.  Assessing Cognitive Performance in Badminton Players: A Reproducibility and Validity Study.

Authors:  Tanja van de Water; Barbara Huijgen; Irene Faber; Marije Elferink-Gemser
Journal:  J Hum Kinet       Date:  2017-01-30       Impact factor: 2.193

3.  Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers.

Authors:  Aitana Calvo; Mercedes González-Hidalgo; Ana Terleira; Nieves Fernández; Antonio Portolés
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.